These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2481390)

  • 21. Accelerating effect of zinc ions on the surface-mediated activation of factor XII and prekallikrein.
    Shimada T; Kato H; Iwanaga S
    J Biochem; 1987 Oct; 102(4):913-21. PubMed ID: 3436959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the activation of Hageman factor (factor XII) by complement subcomponent C1q.
    Rehmus EH; Greene BM; Everson BA; Ratnoff OD
    J Clin Invest; 1987 Aug; 80(2):516-21. PubMed ID: 3038961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the coagulant activity and surface binding of high molecular weight kininogen.
    Colman RW; Silver LD; Purdon AD; Chang JJ; Scott CF
    Trans Assoc Am Physicians; 1984; 97():113-23. PubMed ID: 6336014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies raised against 167-180 aa sequence of human carbonic anhydrase XII inhibit its enzymatic activity.
    Dekaminaviciute D; Kairys V; Zilnyte M; Petrikaite V; Jogaite V; Matuliene J; Gudleviciene Z; Vullo D; Supuran CT; Zvirbliene A
    J Enzyme Inhib Med Chem; 2014 Dec; 29(6):804-10. PubMed ID: 24400872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A monoclonal antibody (H227) recognizing a new epitope of 4F2 molecular complex associated with T cell activation.
    Nakao M; Kubo K; Hara A; Hirohashi N; Futagami E; Shichijo S; Sagawa K; Itoh K
    Cell Immunol; 1993 Nov; 152(1):226-33. PubMed ID: 7694808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding and activation properties of human factor XII, prekallikrein, and derived peptides with acidic lipid vesicles.
    Griep MA; Fujikawa K; Nelsestuen GL
    Biochemistry; 1985 Jul; 24(15):4124-30. PubMed ID: 3876845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation.
    Shimada T; Sugo T; Kato H; Yoshida K; Iwanaga S
    J Biochem; 1985 Feb; 97(2):429-39. PubMed ID: 2861197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of the plasma kallikrein-kinin system inhibitor, haemaphysalin, from hard tick, Haemaphysalis longicornis.
    Kato N; Iwanaga S; Okayama T; Isawa H; Yuda M; Chinzei Y
    Thromb Haemost; 2005 Feb; 93(2):359-67. PubMed ID: 15711755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The plasma bradykinin-forming pathways and its interrelationships with complement.
    Kaplan AP; Ghebrehiwet B
    Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
    Joseph K; Ghebrehiwet B; Peerschke EI; Reid KB; Kaplan AP
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8552-7. PubMed ID: 8710908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta 2-glycoprotein I and anti-beta 2-glycoprotein I.
    Schousboe I; Rasmussen MS
    Thromb Haemost; 1995 May; 73(5):798-804. PubMed ID: 7482406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.
    Nilsson B; Nilsson Ekdahl K; Avila D; Nilsson UR; Lambris JD
    Biochem J; 1990 May; 268(1):55-61. PubMed ID: 1693076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of activation and autoactivation of human factor XII.
    Tankersley DL; Finlayson JS
    Biochemistry; 1984 Jan; 23(2):273-9. PubMed ID: 6607744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces.
    Citarella F; Ravon DM; Pascucci B; Felici A; Fantoni A; Hack CE
    Eur J Biochem; 1996 May; 238(1):240-9. PubMed ID: 8665943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen.
    Lämmle B; Berrettini M; Griffin JH
    Semin Thromb Hemost; 1987 Jan; 13(1):106-14. PubMed ID: 3494310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of plant inhibitors directed against plasma kallikrein and factor XII.
    Oliva ML; Sampaio MU; Sampaio CA
    Adv Exp Med Biol; 1989; 247A():467-71. PubMed ID: 2603813
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet-coagulant protein interactions in contact activation.
    Walsh PN; Griffin JH
    Ann N Y Acad Sci; 1981; 370():241-52. PubMed ID: 7023319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel anti-EGFR monoclonal antibody inhibiting tumor cell growth by recognizing different epitopes from cetuximab.
    Hong KW; Kim CG; Lee SH; Chang KH; Shin YW; Ryoo KH; Kim SH; Kim YS
    J Biotechnol; 2010 Jan; 145(1):84-91. PubMed ID: 19828124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.